Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
26.46
-0.40 (-1.47%)
At close: Apr 28, 2026, 4:00 PM EDT
26.45
0.00 (-0.02%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Jade Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Selling, General & Admin | 20.42 | 8.61 |
| Research & Development | 93.12 | 55.87 |
| Operating Expenses | 113.54 | 64.48 |
| Operating Income | -113.54 | -64.48 |
| Interest Expense | -3.6 | - |
| Interest & Investment Income | 7.78 | 2.32 |
| Other Non Operating Income (Expenses) | 3.59 | - |
| EBT Excluding Unusual Items | -105.77 | -62.16 |
| Other Unusual Items | -21.58 | -31.8 |
| Pretax Income | -127.35 | -93.96 |
| Income Tax Expense | 0.06 | - |
| Net Income | -127.41 | -93.96 |
| Preferred Dividends & Other Adjustments | -27.27 | - |
| Net Income to Common | -100.14 | -93.96 |
| Shares Outstanding (Basic) | 31 | 3 |
| Shares Outstanding (Diluted) | 31 | 3 |
| Shares Change (YoY) | 893.82% | - |
| EPS (Basic) | -3.19 | -29.78 |
| EPS (Diluted) | -3.19 | -29.78 |
| Free Cash Flow | -94.89 | -45.23 |
| Free Cash Flow Per Share | -3.03 | -14.33 |
| EBITDA | -113.52 | - |
| D&A For EBITDA | 0.03 | - |
| EBIT | -113.54 | -64.48 |
Source: S&P Capital IQ. Standard template.
Financial Sources.